The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000861358p
Ethics application status
Help: Ethics application status
Not yet submitted
Date submitted
Help: Date submitted
16/06/2026
Date registered
Help: Date registered
15/07/2026
Date last updated
Help: Date last updated
15/07/2026
Date data sharing statement initially provided
Help: Data sharing statement date
15/07/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
A Multi-Site Randomised Controlled Trial of Digital Psychosocial Screening and Support on Quality of Life of Young People with Chronic Illness in Hospital Settings
Scientific title
A Multi-Site Randomised Controlled Trial of Digital Psychosocial Screening and Support on Quality of Life of Young People with Chronic Illness in Hospital Settings
Additional trial identifiers [1] 317593 0
Nil
Universal Trial Number (UTN)
Trial acronym
Screen and Connect
Related trial records

Health condition
Health condition(s) studied:
Quality of life 342354 0
Chronic Illness 342771 0
Condition category
Condition code
Public Health 338488 338488 0 0
Health service research

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
The intervention is a brief, youth-friendly digital psychosocial screening process delivered as part of hospital-based care. Participants allocated to the intervention group will complete an online questionnaire designed specifically for this study assessing areas such as emotional wellbeing, social connection, safety, substance use, sexual health, practical support needs, and confidence managing their health. The questionnaire will be designed to be brief and take no longer than 5 to 10 minutes. Responses indicating concern, risk, or a request for help will be reviewed by the clinical team, who will provide::
-appropriate follow-up, such as with an Adolescent and Young Adult Physician,
-brief support such as information and/or counselling,
-referral to an appropriate community service, hospital department or primary healthcare (GP), or,
-escalation according to local clinical pathways, such as the acute mental health service.
The screening is not diagnostic, but is intended to identify unmet needs early and improve connection to support
Fidelity to the screening component will be monitored through REDCap audit data, which automatically captures screening offer rates, completion rates, and item-level response patterns across all sites. For the targeted support pathway, hospital notes will document the assessment, support offered, and referrals made,
Participant experience of the intervention will be captured through the patient reported experience measure at follow-up
Intervention code [1] 334398 0
Early detection / Screening
Description of the comparator or control
Participants allocated to the standard care group will receive the full range of clinical care, investigation, treatment, and referral that would ordinarily be provided during their hospital contact, with no restrictions placed on the care they receive. Standard care at each participating site may include referral to social work, psychology, or other allied health services where this is initiated by the treating clinical team through usual clinical pathways.
Control group
Active

Outcomes
Primary outcome [1] 345771 0
Health-Related Quality of Life
Timepoint [1] 345771 0
Baseline and 6 month followup
Secondary outcome [1] 463258 0
Depressive symptoms
Timepoint [1] 463258 0
baseline and 6 month follow-up
Secondary outcome [2] 463259 0
Anxiety symptoms
Timepoint [2] 463259 0
baseline and 6 month follow-up
Secondary outcome [3] 463260 0
Social Connectedness
Timepoint [3] 463260 0
baseline and 6 month followup
Secondary outcome [4] 464636 0
Patient Reported Experience of Health Care
Timepoint [4] 464636 0
6 month follow-up
Secondary outcome [5] 464637 0
Health service utilisation
Timepoint [5] 464637 0
6 month follow-up

Eligibility
Key inclusion criteria
1. are aged 12 to 25 years at the time of enrolment;
2. have a clinician-diagnosed chronic physical health condition that has lasted, or is expected to last, for at least 3 months and requires ongoing medical care, treatment, monitoring or self-management, and/or has a continuing impact on daily functioning;
3. are receiving care through a participating hospital-based inpatient, outpatient or emergency department service;
4. are able to complete the study questionnaires in English;
5. are able to provide informed consent, or, for participants aged under 18 years, provide assent with parent/guardian consent where required;
6. have access to an internet-enabled device or can complete the study questionnaires using a study-provided device where available.
Minimum age
13 Years
Maximum age
25 Years
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
1. are medically unstable, acutely distressed, intoxicated, sedated or otherwise unable to engage with the consent process at the time of recruitment;
2. are unable to provide informed consent and, where required, parent/guardian consent cannot be obtained;
3. are unable to complete the study questionnaires in English;
4. do not have access to an internet-enabled device and a study device is not available;
5. have already been enrolled in the study;
6. are considered by the treating clinician or recruiting staff member to be inappropriate to approach because participation may interfere with urgent clinical care, safety, privacy or wellbeing.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Via randomisation module in REDCAP
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
computer-generated random sequence,
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
Analyses will be undertaken according to a pre-specified statistical analysis plan finalised before database lock and prior to unblinding of study allocation, where applicable. The primary analysis will follow the intention-to-treat principle, with participants analysed according to their randomised group regardless of level of intervention uptake. A secondary per-protocol analysis may be undertaken to explore outcomes among participants who received the intervention as intended.
This sample size is appropriate for a pragmatic, multi-site pilot/early efficacy randomised controlled trial evaluating a hospital-embedded psychosocial/AOD screening and support model for young people with chronic illness. The proposed intervention is intended to identify psychosocial and AOD-related concerns early and connect young people to timely support, with outcomes assessed at baseline and six months across domains including health-related quality of life, mental health, social connectedness, healthcare engagement and psychosocial risk profile.
Assuming a two-sided alpha of 0.05 and 80% power, a total sample of 400 participants, with approximately 200 participants per arm, would provide power to detect an effect size of approximately 0.28 standard deviations between the intervention and control groups on continuous outcomes. This represents a moderate and clinically meaningful difference for psychosocial outcomes such as psychological distress, loneliness, quality of life or composite psychosocial risk scores.
Allowing for approximately 20% attrition at six-month follow-up, the study would retain outcome data for around 320 participants, or approximately 160 participants per arm. Under this assumption, the study would remain powered to detect an effect size of approximately 0.31 standard deviations, which is still within the moderate effect range and appropriate for an intervention designed to improve identification of risk and connection to support.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
QLD
Recruitment hospital [1] 29644 0
Mater Hospital Brisbane - South Brisbane
Recruitment postcode(s) [1] 45989 0
4101 - South Brisbane

Funding & Sponsors
Funding source category [1] 322146 0
Government body
Name [1] 322146 0
Queensland Mental Health Commission
Country [1] 322146 0
Australia
Funding source category [2] 322384 0
Charities/Societies/Foundations
Name [2] 322384 0
Mater Foundation
Country [2] 322384 0
Australia
Primary sponsor type
Hospital
Name
Mater Young Adult Health Centre
Address
Country
Australia
Secondary sponsor category [1] 325039 0
University
Name [1] 325039 0
Mater Research Institute, University of Queensland
Address [1] 325039 0
Country [1] 325039 0
Australia

Ethics approval
Ethics application status
Not yet submitted
Ethics committee name [1] 320677 0
Children’s Health Queensland Hospital and Health Service Human Research Ethics Committee
Ethics committee address [1] 320677 0
Ethics committee country [1] 320677 0
Australia
Date submitted for ethics approval [1] 320677 0
29/07/2026
Approval date [1] 320677 0
Ethics approval number [1] 320677 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 151254 0
Prof Simon Denny
Address 151254 0
Mater Hospital Brisbane, South Brisabne Queensland 4101
Country 151254 0
Australia
Phone 151254 0
+61 731637123
Fax 151254 0
Email 151254 0
Contact person for public queries
Name 151255 0
Simon Denny
Address 151255 0
Mater Hospital Brisbane, South Brisabne Queensland 4101
Country 151255 0
Australia
Phone 151255 0
+61 731637123
Fax 151255 0
Email 151255 0
Contact person for scientific queries
Name 151256 0
Simon Denny
Address 151256 0
Mater Hospital Brisbane, South Brisabne Queensland 4101
Country 151256 0
Australia
Phone 151256 0
+61 731637123
Fax 151256 0
Email 151256 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.